QPRT is upregulated in cancer cells, and this upregulation is resistant to inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) [12], the rate-limiting enzyme of the NAD + salvage pathway [13]. This evidence concerns the gene NAMPT and cancer.